Crossmark

Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson’s disease: a 1-year observational study

Crossref DOI link: https://doi.org/10.1007/s00702-024-02790-2

Published Online: 2024-06-01

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Arce-Sillas, Asiel

Álvarez-Luquín, Diana Denisse

Leyva-Hernández, Jaquelin

Montes-Moratilla, Esteban

Vivas-Almazán, Viridiana

Pérez-Correa, Citzielli

Rodríguez-Ortiz, Ulises

Espinosa-Cárdenas, Raquel

Fragoso, Gladis

Sciutto, Edda

Adalid-Peralta, Laura
Funding

Funding for this research was provided by:

Consejo Nacional de Ciencia y Tecnología (2015-1-261455, CONAHCYT FORDECYT-PRONACES. Ciencia de Frontera No. 2019-64382)
License Information

Text and Data Mining valid from 2024-06-01

Version of Record valid from 2024-06-01
More Information

Article History

Received: 19 February 2024

Accepted: 24 April 2024

First Online: 1 June 2024

Declarations

:

: The authors declare that they have no competing interests.

: This study fulfilled all regulations for research on human subjects established by Mexican laws and international regulations (Helsinki declaration). The Ethics Committee at the Instituto Nacional de Neurología y Neurocirugía, México, approved this protocol with permit No. 95/14. The treatment was indicated by the neurologist taking care of each patient, and the decision was supported by the Ethics Committee, considering the wellbeing of the patients. Informed consent was obtained from all subjects included.

Document is current

Any future updates will be listed below